BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24997827)

  • 1. Therapeutic effect of inulin on enteric hyperoxaluria in rats.
    Tian J; Peng J; Ge WH; Zhang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):313-6. PubMed ID: 24997827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
    Espino-Grosso P; Monsour C; Canales BK
    Urology; 2019 Feb; 124():310.e9-310.e14. PubMed ID: 30412704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of a rat model of low calcium diet related hyperoxaluria].
    Tian J; Guo HQ; Sun XZ; Sun ZY; Lu DS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):134-7. PubMed ID: 22776598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria.
    Toblli JE; Ferder L; Stella I; Angerosa M; Inserra F
    J Urol; 2001 Jul; 166(1):275-80. PubMed ID: 11435885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals.
    Huang HS; Ma MC; Chen J; Chen CF
    Neurourol Urodyn; 2003; 22(2):176-82. PubMed ID: 12579636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary oxalate and calcium oxalate nephrolithiasis.
    Khan SR; Glenton PA; Byer KJ
    J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model.
    Kaplon DM; Penniston KL; Darriet C; Crenshaw TD; Nakada SY
    J Endourol; 2010 Mar; 24(3):355-9. PubMed ID: 20078233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.
    Langman CB; Grujic D; Pease RM; Easter L; Nezzer J; Margolin A; Brettman L
    Am J Nephrol; 2016; 44(2):150-8. PubMed ID: 27529510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polyherbal formulation attenuates hyperoxaluria-induced oxidative stress and prevents subsequent deposition of calcium oxalate crystals and renal cell injury in rat kidneys.
    Bodakhe KS; Namdeo KP; Patra KC; Machwal L; Pareta SK
    Chin J Nat Med; 2013 Sep; 11(5):466-71. PubMed ID: 24359768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
    Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
    Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome.
    Emmett M; Guirl MJ; Santa Ana CA; Porter JL; Neimark S; Hofmann AF; Fordtran JS
    Am J Kidney Dis; 2003 Jan; 41(1):230-7. PubMed ID: 12500242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofibrate feeding to Sprague-Dawley rats increases endogenous biosynthesis of oxalate and causes hyperoxaluria.
    Sharma V; Schwille PO
    Metabolism; 1997 Feb; 46(2):135-9. PubMed ID: 9030817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
    Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.